A Simple, Non-Embarrassing Blood Test for Prostate Cancer and Other Cancers
Abstract
Prostate cancer is the most commonly diagnosed non-skin cancer in America. The mortality rate of prostate carcinoma between the ages of 40 and 60 years is greater in the African-American population than in the white American population. We have conceived a promising new approach to the screening for and monitoring of cancers, especially those cancers of internal organs, which are often undiagnosed until too late for effective treatment. This report covers concepts and devices and experiments performed in at Fisk University (an HBCU) by its PI and his collaborators, with the help of his medical mentor at Karmanos Cancer Institute. They also enlisted specialized help from two small R&D companies in order to perform their system study and design thoroughly and efficiently. We have gathered all of the conceptual parts needed to propose a totally new and extremely promising blood test for prostate state (and other) cancer. It will be a test superior to PSA screening in two useful respects: it will not feel embarrassing or invasive (a major boon among some minority men) and it will have fewer false positives (saving both money and anxiety).
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 1999
- Accession Number
- ADA385850
Entities
People
- Henry J. Caufield
Organizations
- Fisk University